John A. MacKay, Synergistic Technologies Associates and Brian C. Smith, Big Sur Scientific discuss the biggest challenges in cannabis related to extraction.
Leading extraction scientists and researchers from the cannabis industry-John A. MacKay, Synergistic Technologies Associates and Brian C. Smith, Big Sur Scientific-participate in this round-table discussion series. This month they discuss the biggest challenges in cannabis related to extraction.
What is the biggest challenge in cannabis extraction?John A. MacKay: The BIGGEST challenge is:
Botanical integrity is always first. Respect the plant and the compounds that it naturally produces. The anecdotal evidence is from the “whole plant,” not individual compounds. Cannabis includes hemp plant definitions.
Investigate every facet of science. You cannot be an expert in all facets of the plant or the phases of the extraction and separation process, but you need to know enough about each and the interactions between them.
Goals and motives need to be defined. The bigger the boat, the less speed and maneuverability, however also the less it gets affected by the little winds of whim. Know which facets can be varied and which are “non-negotiable.” Motive versus mission versus money.
Get prepared for delays. Licenses, land, electrical, embargos, people, and the unknown are known to be driven toward extending every initial schedule.
Egos and extremism is poison: “this is the only way” or “that never works.”
Solubility. It is all about solubility. Two things to remember: “like dissolves like” and “oil and vinegar salad dressing.” Molecules and compounds do not respect opinions; they adhere to the laws of thermodynamics and mass transfer. It is that simple. It is that complicated-chemistry, physics, and mathematics. You want to have some compounds dissolve in a solvent preferentially over others (laws of thermodynamics), and move them to another vessel for collection (mass transfer).
Test and test and test. Analytical instruments for in-house testing. Good is not a number. You need to know the theoretical yield and the actual yield. You need to know the rate of extraction. You need to know the entire cycle of the process from seed to shelf, and the cost of manufacturing.
Brian Smith: I think the biggest challenge to cannabis extractors right now is the difficulty we have getting consistent analytical data from cannabis analysis laboratories. Some colleagues and I recently did a round-robin study, which was published in Cannabis Science and Technology, comparing potency and pesticide results across five different labs. The measured THC concentration in the same distillate batch varied from 77% to 94%. Samples spiked with six pesticides were submitted, and the false negative rate was 78%. Two of the labs completely missed all the pesticides.
It is impossible to make rational business decisions about how to process extracts, and what material is or isn’t legal to sell, in the face of this much unreliable and conflicting data. This problem will probably not resolve itself until appropriate standard reference materials are available, and governments step up and require all laboratories use the same analytical method.
Look for part II of "Ask the Experts: Extraction" in our June 2019 newsletter. Our series with experts on cultivation will be launching in April, and part II of our analytical methods/cannabis testing series will appear in May.
Inside the University of Maryland School of Pharmacy’s Graduate Program in Medical Cannabis
September 16th 2024Leah Sera, PharmD, MA, the co-program director for the University of Maryland School of Pharmacy’s Graduate Studies in Medical Cannabis program sat down with Cannabis Science and Technology to discuss higher education in medical cannabis.
Studying the Evolution of Cannabis Education: Insights from Stockton University’s Course Instructors
September 13th 2024A leader in cannabis education in New Jersey, Stockton University offers a wide variety of courses to prepare its students to not only succeed in an ever-growing industry, but to also understand its complex history and shape its evolving future. Started six years ago, its Cannabis Studies Program continues its commitment to providing innovative and practical instruction to its students. Two influential figures in this space are Robert Mejia, Teaching Specialist in the Cannabis Studies Program, and Angela Speakman, Instructor in the Cannabis Studies Program. Here, they highlight the program’s practical approach to cannabis education, celebrate the success stories of graduates, discuss the National Cannabis Curriculum Convening, and address challenges in cannabis education and its role in the future.
Medical Cannabis Campaigning with Americans for Safe Access
September 4th 2024As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.
Insights on Cannabis Testing Challenges and Industry Standards: An Interview with Douglas Duncan
August 9th 2024In light of recent headlines concerning cannabis laboratories throughout the country, Cannabis Science and Technology reached out to Douglas Duncan, Laboratory Director of Kairos Labs in Detroit, MI and member of our Editorial Advisory Board for more information. In this interview, Duncan shares his perspectives on lab shopping, major challenges in the industry today, and innovations in cannabis testing laboratories for the future. He also shares insights into consumer practices and the potential effects of a federal rescheduling of cannabis.